美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Gyre Therapeutics

7.65

+0.15002.00%

盘后：7.51-0.1400-1.83%18:21 EDT

成交量：9.67万

成交额：75.19万

市值：7.42亿

市盈率：340.24

高：7.98

开：7.66

低：7.65

收：7.50

52周最高：12.42

52周最低：6.11

股本：9,696.36万

流通股本：2,052.30万

量比：0.69

换手率：0.47%

股息：- -

股息率：- -

每股收益(TTM):0.0225

每股收益(LYR):0.0481

净资产收益率：8.21%

总资产收益率：4.93%

市净率：7.00

市盈率(LYR):159.12

数据加载中...

总览公司新闻资讯公告

Gyre Therapeutics宣布中国药监局对海酮内酯治疗慢性乙肝肝纤维化新药申请授予优先审评资格

BUZZ--美国股票走势-Natera、Pacira 生物科学公司、Kezar 生命科学公司

BUZZ--美国股票走势-班布尔，迪克体育用品公司

BUZZ-Gyre Therapeutics 因年度营收前景不佳而下跌

BUZZ-Gyre Therapeutics 在完成 3 亿美元收购 Cullgen 的交易后下跌

Gyre Therapeutics达成收购Cullgen协议，获取靶向蛋白质降解平台及研发管线

Gyre Therapeutics, Inc.盘中异动快速上涨9.77%

Gyre Therapeutics与中国药监局就海通酮有条件上市路径及优先审评资格达成共识，新药上市申请前会议取得积极进展

Gyre Therapeutics：指引反映Etorel商业化进程慢于预期，因中国集中采购政策的不确定性

Gyre Therapeutics：预计将在2026年提交Hydronidone治疗与Mash相关的肝纤维化的美国IND申请

Gyre Therapeutics 发布2025年第三季度及至今财务业绩并提供业务更新

Gyre Therapeutics宣布完成针对尘肺病的Pirfenidone胶囊三期临床试验患者招募

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/GYRE/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GYRE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GYRE\",,,,,undefined,":{"symbol":"GYRE","market":"US","secType":"STK","nameCN":"Gyre Therapeutics","latestPrice":7.65,"timestamp":1773777600000,"preClose":7.5,"halted":0,"volume":96725,"hourTrading":{"tag":"盘后","latestPrice":7.51,"preClose":7.65,"latestTime":"18:21 EDT","volume":2503,"amount":19125.99,"timestamp":1773786113618,"change":-0.14,"changeRate":-0.018301,"amplitude":0.018301},"delay":0,"changeRate":0.02000000000000005,"floatShares":20523000,"shares":96963600,"eps":0.022484,"marketStatus":"已收盘","change":0.15,"latestTime":"03-17 16:00:00 EDT","open":7.66,"high":7.98,"low":7.65,"amount":751917.2938825,"amplitude":0.044,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.022484,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1773820800000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":7.5,"preHourTrading":{"tag":"盘前","latestPrice":7.75,"preClose":7.5,"latestTime":"09:20 EDT","volume":2768,"amount":21167.336112,"timestamp":1773753631224,"change":0.25,"changeRate":0.033333,"amplitude":0.061333},"postHourTrading":{"tag":"盘后","latestPrice":7.51,"preClose":7.65,"latestTime":"18:21 EDT","volume":2503,"amount":19125.99,"timestamp":1773786113618,"change":-0.14,"changeRate":-0.018301,"amplitude":0.018301},"volumeRatio":0.68595,"impliedVol":2.6246,"impliedVolPercentile":0.9787},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GYRE\",,,,,undefined,":{"symbol":"GYRE","floatShares":20523000,"roa":"4.93%","roe":"8.21%","lyrEps":0.048077,"volumeRatio":0.68595,"shares":96963600,"dividePrice":0,"high":7.98,"amplitude":0.044,"preClose":7.5,"low":7.65,"week52Low":6.11,"pbRate":"7.00","psRate":"6.36","week52High":12.4221,"institutionHeld":0.1067,"latestPrice":7.65,"eps":0.022484,"divideRate":0,"volume":96725,"delay":0,"ttmEps":0.022484,"open":7.66,"prevYearClose":7.06,"prevWeekClose":7.555,"prevMonthClose":8.24,"prevQuarterClose":7.06,"fiveDayClose":8.12,"twentyDayClose":8.21,"sixtyDayClose":7.41},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GYRE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-03-12","symbol":"GYRE","fiscalQuarterEnding":"2025/12","expectedEps":0.08,"name":null,"time":"盘前","type":"earning","dateTimestamp":1773288000000,"reportTimeType":"pre","actualEps":0.04},{"market":"US","date":"2025-11-07","symbol":"GYRE","fiscalQuarterEnding":"2025/09","expectedEps":0.05,"name":null,"time":"盘前","type":"earning","dateTimestamp":1762491600000,"reportTimeType":"pre","actualEps":0.05},{"market":"US","date":"2025-08-11","symbol":"GYRE","fiscalQuarterEnding":"2025/06","expectedEps":0.03,"name":null,"time":"盘后","type":"earning","dateTimestamp":1754884800000,"reportTimeType":"post","actualEps":0.02},{"market":"US","date":"2025-05-09","symbol":"GYRE","fiscalQuarterEnding":"2025/03","expectedEps":0.03,"name":null,"time":"盘前","type":"earning","dateTimestamp":1746763200000,"reportTimeType":"pre","actualEps":0},{"market":"US","date":"2025-03-17","symbol":"GYRE","fiscalQuarterEnding":"2024/12","expectedEps":0.04,"name":null,"time":"盘后","type":"earning","dateTimestamp":1742184000000,"reportTimeType":"post","actualEps":0.01}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GYRE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GYRE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1760155200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GYRE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GYRE","date":"2026-03-16","current":340.24195,"percent":0.858051,"low":-11548.718266,"twenty":-14.866799,"median":65.067812,"eighty":112.195163,"high":193.429414,"avg":-670.239564,"sd":2517.867019,"marketCap":689877322},"quantilePoints":[{"date":"2024-04-05","current":-15.607876,"twenty":-15.830217,"median":-15.617068,"eighty":-15.398378,"marketCap":1450486717},{"date":"2024-04-12","current":-31.76291,"twenty":-32.589325,"median":-21.429161,"eighty":-15.61523,"marketCap":1405212396},{"date":"2024-04-19","current":-29.754799,"twenty":-32.477335,"median":-30.585076,"eighty":-15.742078,"marketCap":1316372220},{"date":"2024-04-26","current":-31.531205,"twenty":-31.948274,"median":-30.797472,"eighty":-16.000876,"marketCap":1394961607},{"date":"2024-05-03","current":-27.239192,"twenty":-31.948274,"median":-30.778163,"eighty":-24.631989,"marketCap":1205080075},{"date":"2024-05-10","current":-14.851474,"twenty":-31.774495,"median":-30.223912,"eighty":-24.631989,"marketCap":1301657414},{"date":"2024-05-17","current":-14.909982,"twenty":-31.744918,"median":-29.754799,"eighty":-15.561911,"marketCap":1306785414},{"date":"2024-05-24","current":-12.302842,"twenty":-31.573048,"median":-28.630129,"eighty":-14.89828,"marketCap":1078282562},{"date":"2024-05-31","current":-8605.737804,"twenty":-32.075712,"median":-29.501562,"eighty":-15.108912,"marketCap":890160307},{"date":"2024-06-07","current":-8895.075775,"twenty":-32.90985,"median":-30.136978,"eighty":-15.311743,"marketCap":920088848},{"date":"2024-06-14","current":-9126.546144,"twenty":-8519.763095,"median":-30.585076,"eighty":-15.366351,"marketCap":944031680},{"date":"2024-06-21","current":-8961.210165,"twenty":-8885.155616,"median":-30.816781,"eighty":-15.424018,"marketCap":926929657},{"date":"2024-06-28","current":-8175.864257,"twenty":-8865.315298,"median":-30.894016,"eighty":-15.515947,"marketCap":845695047},{"date":"2024-07-05","current":-9688.68848,"twenty":-8961.210165,"median":-31.531205,"eighty":-15.611553,"marketCap":1002178559},{"date":"2024-07-12","current":-10424.433593,"twenty":-9151.346542,"median":-31.791873,"eighty":-15.679573,"marketCap":1078282562},{"date":"2024-07-15","current":-11094.044316,"twenty":-9210.867496,"median":-31.820836,"eighty":-15.710825,"marketCap":1147545756},{"date":"2024-08-02","current":-11548.718266,"twenty":-9298.495565,"median":-32.139431,"eighty":-15.742078,"marketCap":1194576320},{"date":"2024-08-09","current":-8374.267436,"twenty":-9189.373818,"median":-32.728348,"eighty":-16.000876,"marketCap":866217475},{"date":"2024-08-16","current":-10.635127,"twenty":-9134.812943,"median":-32.641458,"eighty":-15.61523,"marketCap":914301855},{"date":"2024-08-23","current":-11.421808,"twenty":-9126.546144,"median":-31.820836,"eighty":-15.175222,"marketCap":981932798},{"date":"2024-08-30","current":-13.672312,"twenty":-9020.73112,"median":-31.635813,"eighty":-14.375603,"marketCap":1175408659},{"date":"2024-09-06","current":-11.770337,"twenty":-8974.437045,"median":-30.942288,"eighty":-13.816505,"marketCap":1011895874},{"date":"2024-09-13","current":-14.920484,"twenty":-8961.210165,"median":-30.778163,"eighty":-13.696211,"marketCap":1282714046},{"date":"2024-09-20","current":-15.572509,"twenty":-8941.369845,"median":-30.223912,"eighty":-13.816505,"marketCap":1338768556},{"date":"2024-09-27","current":-13.909847,"twenty":-8923.182886,"median":-29.754799,"eighty":-13.90034,"marketCap":1195829555},{"date":"2024-10-04","current":-13.312158,"twenty":-8919.876167,"median":-28.630129,"eighty":-13.654308,"marketCap":1144446254},{"date":"2024-10-11","current":-12.327984,"twenty":-8904.995932,"median":-26.800559,"eighty":-13.325198,"marketCap":1059836795},{"date":"2024-10-18","current":-15.235629,"twenty":-8865.315298,"median":-15.915547,"eighty":-13.300875,"marketCap":1309807059},{"date":"2024-10-25","current":-15.300832,"twenty":-8830.594739,"median":-15.607876,"eighty":-13.325198,"marketCap":1315412510},{"date":"2024-10-31","current":-15.985457,"twenty":-8804.140979,"median":-15.617068,"eighty":-13.405529,"marketCap":1374269746},{"date":"2024-11-08","current":-16.365804,"twenty":-8779.340581,"median":-15.748988,"eighty":-13.558712,"marketCap":1406968211},{"date":"2024-11-15","current":-13.372591,"twenty":-8709.89947,"median":-15.77333,"eighty":-13.558712,"marketCap":1187780244},{"date":"2024-11-22","current":-11.353175,"twenty":-8602.431085,"median":-15.627389,"eighty":-13.295234,"marketCap":1008411696},{"date":"2024-11-29","current":-12.087508,"twenty":-8556.137012,"median":-15.590193,"eighty":-13.126615,"marketCap":1073636622},{"date":"2024-12-06","current":-10.111572,"twenty":-8387.494312,"median":-15.378053,"eighty":-12.781935,"marketCap":898130076},{"date":"2024-12-13","current":-9.449706,"twenty":-8374.267436,"median":-15.329691,"eighty":-12.475931,"marketCap":839341820},{"date":"2024-12-20","current":-10.299987,"twenty":-8344.506959,"median":-15.279098,"eighty":-12.329976,"marketCap":914865419},{"date":"2024-12-27","current":-12.686569,"twenty":-8225.465052,"median":-15.246496,"eighty":-12.302842,"marketCap":1126846431},{"date":"2025-01-03","current":-11.594732,"twenty":-8192.397854,"median":-15.235629,"eighty":-12.152426,"marketCap":1029867264},{"date":"2025-01-10","current":-9.29511,"twenty":-8179.170976,"median":-15.105225,"eighty":-11.98162,"marketCap":825610256},{"date":"2025-01-17","current":-10.435259,"twenty":-3290.168076,"median":-14.953086,"eighty":-11.68749,"marketCap":926880537},{"date":"2025-01-24","current":-10.242013,"twenty":-32.95233,"median":-14.893499,"eighty":-11.536758,"marketCap":909716083},{"date":"2025-01-31","current":-11.111618,"twenty":-32.786274,"median":-14.681409,"eighty":-11.380628,"marketCap":986956128},{"date":"2025-02-07","current":-12.319402,"twenty":-32.658836,"median":-14.539395,"eighty":-11.347378,"marketCap":1094233968},{"date":"2025-02-14","current":-11.382162,"twenty":-32.515952,"median":-14.451664,"eighty":-11.279742,"marketCap":1010986364},{"date":"2025-02-21","current":-12.135819,"twenty":-32.330588,"median":-14.072853,"eighty":-11.345445,"marketCap":1077927736},{"date":"2025-02-28","current":-10.90871,"twenty":-31.809251,"median":-13.976035,"eighty":-11.179254,"marketCap":968933450},{"date":"2025-03-07","current":-10.338636,"twenty":-31.758412,"median":-13.909847,"eighty":-11.12128,"marketCap":918298310},{"date":"2025-03-14","current":-11.556083,"twenty":-31.698577,"median":-13.789262,"eighty":-11.11355,"marketCap":1026434373},{"date":"2025-03-21","current":79.165838,"twenty":-31.423076,"median":-13.627303,"eighty":-11.045914,"marketCap":956719157},{"date":"2025-03-28","current":70.412668,"twenty":-30.971251,"median":-13.353241,"eighty":-10.90871,"marketCap":850937097},{"date":"2025-04-04","current":52.673943,"twenty":-30.878569,"median":-13.283951,"eighty":-10.748316,"marketCap":636564605},{"date":"2025-04-11","current":56.469566,"twenty":-30.809057,"median":-13.129602,"eighty":-10.622099,"marketCap":682434702},{"date":"2025-04-17","current":61.504575,"twenty":-30.778163,"median":-12.849861,"eighty":-10.560868,"marketCap":743282789},{"date":"2025-04-25","current":70.645053,"twenty":-30.585076,"median":-12.780906,"eighty":-10.377285,"marketCap":853745471},{"date":"2025-05-02","current":72.449806,"twenty":-30.310846,"median":-12.626921,"eighty":-10.338636,"marketCap":875555902},{"date":"2025-05-09","current":73.535777,"twenty":-30.136978,"median":-12.473999,"eighty":-10.164715,"marketCap":888679866},{"date":"2025-05-16","current":132.923099,"twenty":-29.947887,"median":-12.417259,"eighty":-9.938068,"marketCap":963825388},{"date":"2025-05-23","current":136.20365,"twenty":-29.754799,"median":-12.327984,"eighty":-9.652614,"marketCap":987612669},{"date":"2025-05-30","current":117.840031,"twenty":-29.349619,"median":-12.308068,"eighty":-9.440044,"marketCap":854458067},{"date":"2025-06-06","current":99.64599,"twenty":-28.753768,"median":-12.251767,"eighty":50.257139,"marketCap":722533070},{"date":"2025-06-13","current":100.896253,"twenty":-28.630129,"median":-12.168656,"eighty":56.159719,"marketCap":731598729},{"date":"2025-06-20","current":104.146938,"twenty":-27.795567,"median":-12.087508,"eighty":59.335648,"marketCap":755169444},{"date":"2025-06-27","current":92.269436,"twenty":-26.976012,"median":-11.969641,"eighty":62.92987,"marketCap":669045678},{"date":"2025-07-03","current":101.646411,"twenty":-26.790554,"median":-11.75017,"eighty":66.71,"marketCap":737038125},{"date":"2025-07-11","current":97.645568,"twenty":-23.367997,"median":-11.701017,"eighty":68.524795,"marketCap":708028014},{"date":"2025-07-18","current":92.394462,"twenty":-17.913275,"median":-11.686523,"eighty":70.505622,"marketCap":669952244},{"date":"2025-07-25","current":92.269436,"twenty":-17.24169,"median":-11.594732,"eighty":71.634434,"marketCap":669045678},{"date":"2025-08-01","current":88.143567,"twenty":-16.863516,"median":-11.531927,"eighty":73.525921,"marketCap":639129001},{"date":"2025-08-08","current":90.018962,"twenty":-16.53533,"median":-11.498109,"eighty":77.782591,"marketCap":652727491},{"date":"2025-08-15","current":179.246974,"twenty":-16.326683,"median":-11.42614,"eighty":87.268382,"marketCap":746563646},{"date":"2025-08-22","current":164.643977,"twenty":-16.268001,"median":-11.353175,"eighty":89.218793,"marketCap":685742166},{"date":"2025-08-29","current":180.563196,"twenty":-16.183906,"median":-11.256552,"eighty":90.29402,"marketCap":752045713},{"date":"2025-09-05","current":165.298192,"twenty":-16.049822,"median":-11.217903,"eighty":91.769331,"marketCap":688466969},{"date":"2025-09-12","current":177.074053,"twenty":-16.011538,"median":-11.179254,"eighty":92.594504,"marketCap":737513429},{"date":"2025-09-19","current":167.696978,"twenty":-15.943032,"median":-11.12128,"eighty":93.569709,"marketCap":698457915},{"date":"2025-09-26","current":158.974119,"twenty":-15.763593,"median":-11.111618,"eighty":95.145041,"marketCap":662127204},{"date":"2025-10-03","current":163.989763,"twenty":-15.70726,"median":-11.048813,"eighty":96.920416,"marketCap":683017363},{"date":"2025-10-10","current":155.921118,"twenty":-15.633582,"median":-10.966684,"eighty":99.846032,"marketCap":649411455},{"date":"2025-10-17","current":190.594485,"twenty":-15.61523,"median":-10.876478,"eighty":100.896253,"marketCap":793826030},{"date":"2025-10-24","current":179.472839,"twenty":-15.600803,"median":-10.763776,"eighty":101.646411,"marketCap":747504374},{"date":"2025-10-31","current":166.824692,"twenty":-15.546428,"median":-10.691308,"eighty":105.447211,"marketCap":694824844},{"date":"2025-11-07","current":160.064476,"twenty":-15.429294,"median":-10.618842,"eighty":111.643728,"marketCap":666668543},{"date":"2025-11-14","current":110.418625,"twenty":-15.377823,"median":-10.570531,"eighty":112.102687,"marketCap":734394278},{"date":"2025-11-21","current":102.355879,"twenty":-15.373231,"median":-10.435259,"eighty":110.254637,"marketCap":680768953},{"date":"2025-11-28","current":105.908954,"twenty":-15.35855,"median":-10.377285,"eighty":109.598685,"marketCap":704400452},{"date":"2025-12-05","current":107.958805,"twenty":-15.300832,"median":-10.338636,"eighty":109.462028,"marketCap":718034009},{"date":"2025-12-12","current":107.548834,"twenty":-15.279098,"median":-10.299987,"eighty":109.871999,"marketCap":715307298},{"date":"2025-12-19","current":100.442685,"twenty":-15.279098,"median":-10.179208,"eighty":109.598685,"marketCap":668044300},{"date":"2025-12-26","current":98.256178,"twenty":-15.261711,"median":-10.046352,"eighty":109.489359,"marketCap":653501839},{"date":"2026-01-02","current":96.479641,"twenty":-15.250843,"median":-9.954769,"eighty":109.29804,"marketCap":641686089},{"date":"2026-01-09","current":103.449133,"twenty":-15.243518,"median":-9.652614,"eighty":109.106721,"marketCap":688040184},{"date":"2026-01-16","current":105.22567,"twenty":-15.23799,"median":-9.652614,"eighty":108.560094,"marketCap":699855933},{"date":"2026-01-23","current":110.008655,"twenty":-15.222589,"median":-9.517342,"eighty":109.134052,"marketCap":731667567},{"date":"2026-01-30","current":112.195163,"twenty":-15.163907,"median":-9.314435,"eighty":109.544022,"marketCap":746210028},{"date":"2026-02-06","current":102.629193,"twenty":-15.092184,"median":51.163441,"eighty":109.680679,"marketCap":682586761},{"date":"2026-02-13","current":106.865551,"twenty":-15.037849,"median":54.920332,"eighty":109.544022,"marketCap":710762779},{"date":"2026-02-20","current":115.064954,"twenty":-14.972646,"median":56.469566,"eighty":109.844668,"marketCap":765297008},{"date":"2026-02-27","current":116.431521,"twenty":-14.918384,"median":59.41311,"eighty":110.555282,"marketCap":774386046},{"date":"2026-03-06","current":107.002208,"twenty":-14.903389,"median":60.420111,"eighty":111.484548,"marketCap":711671683},{"date":"2026-03-13","current":141.117848,"twenty":-14.871908,"median":65.067812,"eighty":112.058506,"marketCap":709399423},{"date":"2026-03-16","current":137.234399,"twenty":-14.866799,"median":65.067812,"eighty":112.195163,"marketCap":689877322}],"updateTime":1773795975389},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GYRE\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1191454263","title":"Gyre Therapeutics宣布中国药监局对海酮内酯治疗慢性乙肝肝纤维化新药申请授予优先审评资格","url":"https://stock-news.laohu8.com/highlight/detail?id=1191454263","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191454263?lang=zh_cn&edition=fundamental","pubTime":"2026-03-17 19:03","pubTimestamp":1773745425,"startTime":"0","endTime":"0","summary":"Gyre Therapeutics今日宣布，中国国家药品监督管理局（NMPA）已正式授予其核心药物海酮内酯（研发代号F351）的新药上市申请（NDA）优先审评资格。该药物拟用于治疗慢性乙型肝炎（CHB）引发的肝纤维化。\n此次优先审评资格的获得，意味着该药物的审评流程有望大幅提速，为亟需创新疗法的肝纤维化患者带来了新的希望。肝纤维化是慢性肝病进展为肝硬化和肝癌的关键环节，目前临床治疗选择有限。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GYRE","BK4139"],"gpt_icon":0},{"id":"2619072158","title":"BUZZ--美国股票走势-Natera、Pacira 生物科学公司、Kezar 生命科学公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2619072158","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619072158?lang=zh_cn&edition=fundamental","pubTime":"2026-03-13 00:00","pubTimestamp":1773331241,"startTime":"0","endTime":"0","summary":".N美东时间11时30分，道琼斯工业平均指数.DJI下跌1.38%，报46,764.08点。标普500指数.SPX下跌1.24%，报6,692.11点；纳斯达克综合指数.IXIC下跌1.61%，报22,349.55点。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nL4S4001PO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DG","BX","KKR","CE","MOS","LU0795875169.SGD","XOMX","KZR","GYRE","LU2065170008.USD","AALG","CUBI","JBL","GFS","BMBL","SG9999002232.USD","AAL","GIII","DAL","UAL","BK4504","CASH","LUV","TBBK","INTS","OWL","PCRX","NOG","NTRA","LU0130102774.USD","SG9999014906.USD","KMLI","CF","MELI","WLTH","DKS","ARES","SM","SPRC","XOMZ","XOMO","RPID","DOW","MUR","BBW","IE00B19Z3B42.SGD","LU0345781412.USD"],"gpt_icon":1},{"id":"2618447131","title":"BUZZ--美国股票走势-班布尔，迪克体育用品公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2618447131","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618447131?lang=zh_cn&edition=fundamental","pubTime":"2026-03-12 19:53","pubTimestamp":1773316407,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nL4T40015I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0009354923.USD","LU0310800965.SGD","LU1585245621.USD","BK4200","BK4155","CUBI","BX","GFS","LU0072461881.USD","BK4500","LU2380233275.USD","BMBL","IE00B3QW5Z07.USD","MOS","DG","BK4008","DKS","LU0070302665.USD","RPID","BK4588","BK4211","DAL","UAL","IE00BFMHRM44.USD","LU0630314457.HKD","BK4135","BK4539","LUV","IE0004445239.USD","BK4077","CASH","LU0345780950.USD","AALG","BK4585","LU0208291251.USD","GYRE","IE00BLSP4239.USD","LU1989763427.SGD","LU0320765489.SGD","CF","LU0345781412.USD","BK4141","BK4139","BK4504","BK4547","IE00BN8TJ469.HKD","BK4093","TBBK","LU2264538146.SGD","AAL"],"gpt_icon":0},{"id":"2618413955","title":"BUZZ-Gyre Therapeutics 因年度营收前景不佳而下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2618413955","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618413955?lang=zh_cn&edition=fundamental","pubTime":"2026-03-12 19:20","pubTimestamp":1773314452,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260312:nL4T400134:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GYRE","BK4139"],"gpt_icon":0},{"id":"2616353525","title":"BUZZ-Gyre Therapeutics 在完成 3 亿美元收购 Cullgen 的交易后下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2616353525","media":"路透中文","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616353525?lang=zh_cn&edition=fundamental","pubTime":"2026-03-02 22:22","pubTimestamp":1772461353,"startTime":"0","endTime":"0","summary":"BUZZ-Gyre Therapeutics 在完成 3 亿美元收购 Cullgen 的交易后下跌3月2日 - ** 生物技术公司Gyre Therapeutics GYRE.O股价盘前下跌3.88%至7.92美元 ** GYRE表示，它将以全股票交易的方式收购私营生物技术公司Cullgen，交易价值约为3亿美元。** 该交易将使 GYRE 获得 Cullgen 的专有平台，该平台旨在去除几种炎症性疾病、癌症和疼痛中的致病蛋白。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260302:nL4S3ZQ1FY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GYRE","BK4139"],"gpt_icon":0},{"id":"1112195728","title":"Gyre Therapeutics达成收购Cullgen协议，获取靶向蛋白质降解平台及研发管线","url":"https://stock-news.laohu8.com/highlight/detail?id=1112195728","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112195728?lang=zh_cn&edition=fundamental","pubTime":"2026-03-02 21:01","pubTimestamp":1772456500,"startTime":"0","endTime":"0","summary":"Gyre Therapeutics已正式签署协议，将全面收购生物科技公司Cullgen。此项交易的核心标的为Cullgen旗下创新的靶向蛋白质降解技术平台及其相关研发管线。通过本次收购，Gyre Therapeutics旨在强化其在肿瘤治疗领域的技术布局，拓展创新药物研发能力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GYRE"],"gpt_icon":0},{"id":"2601387836","title":"Gyre Therapeutics, Inc.盘中异动 快速上涨9.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601387836","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601387836?lang=zh_cn&edition=fundamental","pubTime":"2026-01-05 22:32","pubTimestamp":1767623538,"startTime":"0","endTime":"0","summary":"北京时间2026年01月05日22时32分，Gyre Therapeutics, Inc.股票出现异动，股价急速上涨9.77%。Gyre Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.33%。Gyre Therapeutics, Inc.公司简介：Gyre Therapeutics Inc 是一家商业阶段的制药公司，开发和商业化针对器官疾病的小分子抗炎和抗纤维化药物，特别关注器官纤维化。该公司的可报告部门是 Gyre Pharmaceuticals，该公司从在中国销售 艾思瑞和某些仿制药、Gyre 和其他部门获得最大收入。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105223219a49f643c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260105223219a49f643c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4007","BK4539","GYRE"],"gpt_icon":0},{"id":"1160636585","title":"Gyre Therapeutics与中国药监局就海通酮有条件上市路径及优先审评资格达成共识，新药上市申请前会议取得积极进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1160636585","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160636585?lang=zh_cn&edition=fundamental","pubTime":"2026-01-05 20:01","pubTimestamp":1767614508,"startTime":"0","endTime":"0","summary":"在近期举行的新药上市申请前沟通会议上，Gyre Therapeutics与中国国家药品监督管理局药品审评中心就海通酮的注册路径达成重要共识。根据会议结果，该药物已明确符合中国附条件批准上市的标准，并同时获得优先审评资格认定。Gyre Therapeutics表示，公司将严格遵循药监局要求，有序推进后续申报工作。此次 alignment 不仅体现了中国监管机构对创新药研发的支持力度，也展现出Gyre Therapeutics在全球肝病治疗领域的技术领先地位。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GYRE"],"gpt_icon":0},{"id":"1137762718","title":"Gyre Therapeutics：指引反映Etorel商业化进程慢于预期，因中国集中采购政策的不确定性","url":"https://stock-news.laohu8.com/highlight/detail?id=1137762718","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137762718?lang=zh_cn&edition=fundamental","pubTime":"2025-11-07 19:09","pubTimestamp":1762513749,"startTime":"0","endTime":"0","summary":"Gyre Therapeutics：指引反映Etorel商业化进程慢于预期，因中国集中采购政策的不确定性","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GYRE","BK4139"],"gpt_icon":0},{"id":"1118444603","title":"Gyre Therapeutics：预计将在2026年提交Hydronidone治疗与Mash相关的肝纤维化的美国IND申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1118444603","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118444603?lang=zh_cn&edition=fundamental","pubTime":"2025-11-07 19:07","pubTimestamp":1762513646,"startTime":"0","endTime":"0","summary":"Gyre Therapeutics：预计将在2026年提交Hydronidone治疗与Mash相关的肝纤维化的美国IND申请","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GYRE"],"gpt_icon":0},{"id":"1128737109","title":"Gyre Therapeutics 发布2025年第三季度及至今财务业绩并提供业务更新","url":"https://stock-news.laohu8.com/highlight/detail?id=1128737109","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1128737109?lang=zh_cn&edition=fundamental","pubTime":"2025-11-07 19:03","pubTimestamp":1762513390,"startTime":"0","endTime":"0","summary":"Gyre Therapeutics 发布2025年第三季度及至今财务业绩并提供业务更新","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GYRE"],"gpt_icon":0},{"id":"1123064053","title":"Gyre Therapeutics宣布完成针对尘肺病的Pirfenidone胶囊三期临床试验患者招募","url":"https://stock-news.laohu8.com/highlight/detail?id=1123064053","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1123064053?lang=zh_cn&edition=fundamental","pubTime":"2025-10-15 19:00","pubTimestamp":1760526008,"startTime":"0","endTime":"0","summary":"Gyre Therapeutics宣布完成针对尘肺病的Pirfenidone胶囊三期临床试验患者招募。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GYRE"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":12,"code":"91000000","status":"200"}]}}